Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Anand Tandra"'
Autor:
Francesco Passamonti, James M. Foran, Anand Tandra, Valerio De Stefano, Maria Laura Fox, Ahmad H. Mattour, Mary Frances McMullin, Andrew Charles Perkins, Gabriela Rodríguez-Macias, Hassan Sibai, Qin Qin, Yan Sun, Jalaja Potluri, Jason Harb, Jonathan How
Publikováno v:
Blood. 140:583-585
Autor:
Cristina Papayannidis, Blanca Boluda, Jonathan Canaani, Pascal Turlure, Ann De Becker, Anand Tandra, Dina Elsouda, Arnaud Houweling, Anil Upadhyay, Isabelle Wouters, Paresh Vyas
Publikováno v:
Blood. 140:11641-11643
Autor:
Francesco Passamonti, James M. Foran, Anand Tandra, Valerio De Stefano, Maria Laura Fox, Ahmad Hatem Mattour, Mary Frances McMullin, Andrew Perkins, Gabriela Rodriguez-Macias, Hassan Sibai, Qin Q. Qin, Jalaja Potluri, Jonathan B. How
Publikováno v:
Journal of Clinical Oncology. 40:7015-7015
7015 Background: Ruxolitinib (RUX), a Janus kinase (JAK) 1/2 inhibitor, is the current standard of care for patients (pts) with myelofibrosis (MF) that improves splenomegaly and disease symptoms with limited impact on disease biology. Many pts lose r
Autor:
Leland Metheny, Bernadette McQuigg, Richard J. Creger, Ehsan Malek, Fahrettin Covut, Paolo Caimi, Merle Kolk, Anand Tandra, Ben K. Tomlinson, Folashade Otegbeye, Lauren Brister, Hillard M. Lazarus, Brenda W. Cooper, Marcos de Lima
Publikováno v:
Leukemialymphoma. 59(7)
Anti-thymocyte globulin (ATG) is often added to hematopoietic stem cell transplant conditioning regimens to prevent graft rejection and reduce graft-versus-host disease (GVHD). Doses used in retrospective and prospective clinical trials have ranged f
Autor:
John R. Edwards, Anand Tandra, Lauren E. Caldemeyer, Michael J. Dugan, Luke P. Akard, Dawn R. Wagenknecht
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 23(11)
Mixed chimerism (MC), a persistent or increasing number of host cells after allogeneic hematopoietic stem cell transplantation (HSCT), is a predictor of disease relapse. Donor lymphocyte infusions (DLI) have the potential to enhance the graft-versus-
Publikováno v:
Hepatology (Baltimore, Md.). 61(6)
Publikováno v:
Hepatology (Baltimore, Md.). 61(4)
Autor:
Anand Tandra, Amy D. Shapiro
Publikováno v:
Textbook of Hemophilia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fc27f2184402a2fa0435670bd9a0821
https://doi.org/10.1002/9781118398258.ch15
https://doi.org/10.1002/9781118398258.ch15
Publikováno v:
Journal of Blood Medicine
Dear editor Acquired hemophilia (AH) is a rare (incidence is 1 per 1.5 million) but often severe bleeding disorder characterized by autoantibodies to coagulation factor VIII (FVIII). It is associated with life-threatening bleeding and ~20% mortality.
Autor:
Anand Tandra, Ehsan Malek, Raisa Pinto, Fahrettin Covut, Lauren Brister, Hillard M. Lazarus, Ben K. Tomlinson, David Yao, Marcos deLima, Paolo Caimi, Leland Metheny, Brenda W. Cooper
Publikováno v:
Blood. 128:5788-5788
ATG appears to reduce the incidence of acute and chronic GVHD after allogeneic hematopoietic stem cell transplantation (HSCT). Potential risks of this strategy include viral reactivation, delayed immune recovery and increased relapse rates. The ideal